← Other lipid agents × cardiovascular events

TrialPloS one2012

Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data.

Alexander Tenenbaum et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation, not cause

Went with fewer cardiovascular events

−46%−68% to −6%

3 in 100 instead of 6

Bigger than 9 in 10 for cardiovascular events

As reported

OR 0.54, 95% CI 0.32–0.94

One number in the abstract

the abstract, start to end

… reduced risk of MACE with odds ratio of 0.54, 95% confidence interval …

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
OR 0.540.32–0.94
StatinsOther lipid agentsCardiovascular events
1 / 3

9 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22523582